Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NIVEEN T BEBAWY

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1659711919
CMS profile
4222630
Location
UNION CITY, NJ

General Payments · PY2019–2022

$1,190.02

  • Reported across 72 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$267.59

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $267.59 16

By paying entity

PY2022 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $306.02 17
PY2020 $237.54 15
PY2021 $378.87 24
PY2022 $267.59 16

Payment records · PY2022 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2022 201920202021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $22.54 02/08/2022 Food and Beverage Undisputed 01/23/2026 885307393 CMS
AKEBIA THERAPEUTICS INC $23.27 07/28/2022 Food and Beverage Undisputed 01/23/2026 885307483 CMS
Amgen Inc. $14.55 04/12/2022 Food and Beverage Undisputed 01/23/2026 939840555 CMS
AstraZeneca Pharmaceuticals LP $14.39 02/15/2022 Food and Beverage Undisputed 01/23/2026 914907509 CMS
AstraZeneca Pharmaceuticals LP $14.83 05/03/2022 Food and Beverage Undisputed 01/23/2026 915844925 CMS
AstraZeneca Pharmaceuticals LP $14.77 08/16/2022 Food and Beverage Undisputed 01/23/2026 915483709 CMS
Bayer HealthCare Pharmaceuticals Inc. $16.83 03/22/2022 Food and Beverage Undisputed 01/23/2026 930319823 CMS
Bayer HealthCare Pharmaceuticals Inc. $24.66 08/31/2022 Food and Beverage Undisputed 01/23/2026 930208791 CMS
CALLIDITAS THERAPEUTICS US INC. $16.38 07/20/2022 Food and Beverage Undisputed 01/23/2026 927064679 CMS
Fresenius USA Marketing, Inc. $20.60 04/05/2022 Food and Beverage Undisputed 01/23/2026 954557613 CMS
Mallinckrodt Hospital Products Inc. $13.15 05/10/2022 Food and Beverage Undisputed 01/23/2026 937475737 CMS
OPKO Pharmaceuticals, LLC $13.40 03/16/2022 Food and Beverage Undisputed 01/23/2026 929021773 CMS
Otsuka America Pharmaceutical, Inc. $15.88 02/02/2022 Food and Beverage Undisputed 01/23/2026 929256089 CMS
Shield Therapeutics Inc $13.29 01/25/2022 Food and Beverage Undisputed 01/23/2026 946404817 CMS
Vifor Pharma, Inc. $14.83 01/17/2022 Food and Beverage Undisputed 01/23/2026 896765221 CMS
Vifor Pharma, Inc. $14.22 07/26/2022 Food and Beverage Undisputed 01/23/2026 896765219 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.